Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 EUR)

NET PROFIT (x1000 EUR)

Share

Cytiva BioProcess R&D AB

Closing information (x1000 EUR)

Closing information 2023/12 2022/12 2021/12
Turnover 1,152,452 More Arrow 1,528,690 Less Arrow 1,445,823
Financial expenses 0 More Arrow 1,037 More Arrow 1,291
Earnings before taxes 542,696 More Arrow 889,799 Less Arrow 770,944
EBITDA 1,105,284 More Arrow 1,481,410 Less Arrow 1,415,350
Total assets 3,329,695 Less Arrow 3,182,048 Less Arrow 2,596,586
Current assets 1,346,013 Less Arrow 1,183,650 Less Arrow 24,127
Current liabilities 1,283,352 More Arrow 2,055,895 Less Arrow 1,314,615
Equity capital 2,046,342 Less Arrow 1,036,457 More Arrow 1,042,884
- share capital 9 Equal arrow 9 More Arrow 10
Employees (average) 0 Equal arrow 0 Equal arrow 0

Financial ratios

Fiscal year 2023/12 2022/12 2021/12
Solvency 61.5% Less Arrow 32.6% More Arrow 40.2%
Turnover per employee
Profit as a percentage of turnover 47.1% More Arrow 58.2% Less Arrow 53.3%
Return on assets (ROA) 16.3% More Arrow 28.0% More Arrow 29.7%
Current ratio 104.9% Less Arrow 57.6% Less Arrow 1.8%
Return on equity (ROE) 26.5% More Arrow 85.9% Less Arrow 73.9%
Change turnover -380,688 More Arrow 199,980 More Arrow 472,114
Change turnover % -25% More Arrow 15% More Arrow 48%
Chg. No. of employees 0 Equal arrow 0 Equal arrow 0
Chg. No. of employees %

Total value of public sale

Fiscal year 2023/12 2022/12 2021/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.